## **Core Concept**
Guillain-Barre Syndrome (GBS) is an autoimmune disorder characterized by rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. The management of GBS involves treatments that modulate the immune response and provide supportive care.

## **Why the Correct Answer is Right**
Plasma exchange (plasmapheresis) and intravenous immunoglobulin (IVIG) are established treatments for GBS, aimed at reducing the levels of circulating antibodies. Supportive care, including mechanical ventilation and physical therapy, is also crucial. Corticosteroids, however, have not been shown to provide significant benefit in the treatment of GBS and are generally not recommended as a first-line treatment.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Plasma exchange is a recognized treatment for GBS, helping to remove autoantibodies from the circulation.
- **Option B:** IVIG is another standard treatment, which works by providing antibodies that compete with the autoantibodies causing the disease.
- **Option D:** Supportive care, including physical therapy and management of complications, is essential in the management of GBS.

## **Why Option C is Incorrect (Correct Answer)**
- **Option C:** Corticosteroids are not typically recommended for the treatment of GBS. While they are effective in many autoimmune conditions, their benefit in GBS is not established, and they are not considered a standard treatment.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that GBS often follows a gastrointestinal or respiratory infection, and patients may present with ascending muscle weakness. Early recognition and treatment with IVIG or plasma exchange can significantly improve outcomes.

## **Correct Answer:** . Corticosteroids